- Details
- Description
-
Packaging Size30t/bottle
-
Strength50mg
-
CompositonOrelabrutinib
-
TreatmentMantle cell lymphoma (MCL) and Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
-
FormTablet
-
Brand宜诺凯(INNOBRUKA)
-
Quantity Unit50mg*30t/Box
-
ManufacturerInnoCare Pharma.,China
Orelabrutinib is a novel, highly selective, irreversible BTK inhibitor with high target selectivity and safety.
- Orelabrutinib sold under the brand name 宜诺凯(INNOBRUKA)® in china.
In China, it is approved for patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), who have received at least one treatment in the past.